Showing results (41-50 of 92) with videos related to
Sort By:
Pageof 10
Experimental Gerontology|May 12, 2026
Interpretable machine learning with SHAP analysis identifies redox-modulating dietary antioxidants for predicting accelerated biological agingBei Zhang, Xinyu Zhang, Lanyue Ma, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 26, 2017
Infections in neuromyelitis optica spectrum disorderXiaonan Zhong, Yifan Zhou, Tingting Lu, et al.Cell Cycle (Georgetown, Tex.)|March 16, 2017
High salt-induced activation and expression of inflammatory cytokines in cultured astrocytesZhezhi Deng, Yuge Wang, Li Zhou, et al.Medicine|February 10, 2025
The efficacy of Sijunzi on immune function in patients with gastrointestinal cancers after surgery: Integrating systematic review and network pharmacologyZhulin Wu, Weiqing Zhang, Wangdong Miao, et al.The Journal of General Virology|January 25, 2006
Amino terminus of the SARS coronavirus protein 3a elicits strong, potentially protective humoral responses in infected patientsXiaofen Zhong, Zufeng Guo, Huanghao Yang, et al.Neuroimmunomodulation|March 30, 2022
Anti-IgLON5 Encephalopathy with Concomitant Herpes Virus EncephalitisYuge Wang, Rui Li, Xiaobo Sun, et al.Frontiers in Public Health|July 1, 2024
Association between machine learning-assisted heavy metal exposures and diabetic kidney disease: a cross-sectional survey and Mendelian randomization analysisRuiqi Zhao, Sen Lin, Mengyao Han, et al.Brain Sciences|June 24, 2022
Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the LiteratureYining Gao, Jie Pan, Dingding Shen, et al.BMC Neurology|July 12, 2019
CLCN2-related leukoencephalopathy: a case report and review of the literatureZhuoxin Guo, Tingting Lu, Lisheng Peng, et al.Expert Opinion on Drug Safety|July 16, 2024
Adverse drug events associated with fluorouracil use in patients with metastatic colorectal cancer: a real-world pharmacovigilance study based on the FDA adverse event reporting systemRuiqi Zhao, Mengyao Han, Sen Lin, et al.Pageof 10